Candel Therapeutics Inc (CADL)
$6.75 -$2.92 (-29.85%) 10:16 PM 12/14/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$134.29M -
Day's Range
$6.20 - $7.07 -
Volume
11,197,276 -
52 Week Low / High
$1.02 - $14.30 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
CADL's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 0
- Strong Buy
- 1
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $9.50
- Target Price
Company News
-
Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors — Sep 4th, 2024
Milestone Pharmaceuticals Inc. MONTREAL and CHARLOTTE, N.C., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced the appoint...
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$